Expanding Patient Care and Your Bottom Line
CMPD Licensing, LLC holds numerous issued US Patents with additional pending patents in the pipeline.
- US Patent 8,327,610
- US Patent 8,464,498
- US Patent 8,663,663
- US Patent 8,895,036
- US Patent 9,078,853
- US Patent 9,186,319
- US Patent 9,271,989
- US Patent 9,468,599
- US Patent 9,468,601
- US Patent 9,592,241
- US Patent 9,707,229
- US Patent 9,717,748
- US Patent 9,724,294
- US Patent 9,724,315
- US Patent 9,925,141
- US Patent 9,962,391
- US Patent 9,999,604
- US Patent 10,064,949
- US Patent 10,105,342
- US Patent 10,105,381
- US Patent 10,231,924
- US Patent 10,434,115
- US Patent 10,525,025
- US Patent 10,610,503
- US Patent 10,617,703
- US Patent 10,660,962
- US Patent 10,792,296
- US Patent 10,813,897
- US Patent 10,813,908
- US Patent 10,898,455
- US Patent 10,898.491
- US Patent 10,966,946
- US Patent 10,973,804
- US Patent 11,173,163
- US Patent 11,207,336
- US Patent 11,213,500
- US Patent 11,213,501
- US Patent 11,278,508
- US Patent 11,278,590
- US Patent 11,311,564
- US Patent 11,324,694
- US Patent 11,446,236
CMPD works with pharmacies all across the nation and we would love to work with you. We firmly believe any pharmacy would benefit from being a licensee. The goal is simple – promoting ethical and clinical strength within every pharmacy licensee and deploying patented treatment options that are sustainable for years – not months. A licensee might be a pharmacy that: (a) either compounds or does not compound, (b) does or does not have a sales division, or (c) serves its local community only or instead a larger area through delivery services.
In addition to the obvious benefit of alleviating concerns about being engaged on potential infringement of CMPD’s patents, licensees may also receive additional services and benefits including, but not limited to, the following:
-
Education related to clinically appropriate approaches (both compounded and commercially available medication options)
-
Assistance on controlling your cost-of-goods
-
Guidance on recommended “best practices” for compliance-driven pharmacy operations
-
Suggestions to mitigate fraud, waste, and abuse concerns of many industry payers and regulators
-
Suggestions for being viewed as a resource by prescribers, patients, payers and plan sponsors